| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Autoimmune Disease Unit, Cedars-Sinai Research Institute and University of California-Los Angeles School of Medicine, Los Angeles, California 90048
Address all correspondence and requests for reprints to: Dr. Sandra M. McLachlan, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Suite B-131, Los Angeles, California 90048.
Autoantibodies to several protein antigens in human autoimmunity
interact with a restricted range of epitopes, whereas diverse epitopes
are recognized by antibodies induced in animals using antigen and
adjuvant. To examine the basis for this difference, we compared the
qualitative nature of antibodies developing in AKR/N mice injected with
purified thyroid peroxidase (TPO) and adjuvant or with TPO expressed on
major histocompatibility complex (MHC) class II+
fibroblasts. Mice injected with purified TPO had higher TPO antibody
levels than TPO+/class II+ fibroblast-treated
mice. Despite lower titers, recipients of TPO+/class
II+ cells developed very high affinity antibodies
(Kd =
10-10 M), comparable with
those of human TPO autoantibodies and about 10-fold higher than those
in purified TPO plus adjuvant-immunized mice. Moreover, more than 90%
of TPO antibodies in TPO+/class II+
fibroblast-injected mice, compared with only approximately 50% in TPO
plus adjuvant-immunized mice, were to the immunodominant region
recognized by patients autoantibodies. Consistent with this epitopic
restriction, TPO+/class II+ fibroblast-injected
mice had TPO antibody epitopic fingerprints similar to those of human
autoantibodies.
In conclusion, mice injected with TPO+/class II+ fibroblasts, but not those injected with purified TPO and adjuvant, develop antibodies closely resembling autoantibodies in human disease. These observations indicate that some animal models based on conventional immunization may not be representative of human diseases with a major humoral component.
This article has been cited by other articles:
![]() |
J. Guo, S. M. McLachlan, P. N. Pichurin, C.-R. Chen, N. Pham, H. A. Aliesky, C. S. David, and B. Rapoport Relationship between Thyroid Peroxidase T Cell Epitope Restriction and Antibody Recognition of the Autoantibody Immunodominant Region in Human Leukocyte Antigen DR3 Transgenic Mice Endocrinology, November 1, 2005; 146(11): 4961 - 4967. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. McLachlan, Y. Nagayama, and B. Rapoport Insight into Graves' Hyperthyroidism from Animal Models Endocr. Rev., October 1, 2005; 26(6): 800 - 832. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Guo, P. N. Pichurin, J. C. Morris, B. Rapoport, and S. M. McLachlan "Naked" Deoxyribonucleic Acid Vaccination Induces Recognition of Diverse Thyroid Peroxidase T Cell Epitopes Endocrinology, August 1, 2004; 145(8): 3671 - 3678. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. P. Ng, J. Paul Banga, and A. W. C. Kung Development of a Murine Model of Autoimmune Thyroiditis Induced with Homologous Mouse Thyroid Peroxidase Endocrinology, February 1, 2004; 145(2): 809 - 816. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Guo, S. M. McLachlan, and B. Rapoport Localization of the Thyroid Peroxidase Autoantibody Immunodominant Region to a Junctional Region Containing Portions of the Domains Homologous to Complement Control Protein and Myeloperoxidase J. Biol. Chem., October 18, 2002; 277(43): 40189 - 40195. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Pichurin, X.-M. Yan, L. Farilla, J. Guo, G. D. Chazenbalk, B. Rapoport, and S. M. McLachlan Naked TSH Receptor DNA Vaccination: A TH1 T Cell Response in Which Interferon-{gamma} Production, Rather than Antibody, Dominates the Immune Response in Mice Endocrinology, August 1, 2001; 142(8): 3530 - 3536. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Schuppert, D. Ehrenthal, A. Frilling, K. Suzuki, G. Napolitano, and L. D. Kohn Increased Major Histocompatibility Complex (MHC) Expression in Nontoxic Goiters Is Associated with Iodide Depletion, Enhanced Ability of the Follicular Thyroglobulin to Increase MHC Gene Expression, and Thyroid Autoantibodies J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 858 - 867. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |